Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-21
2006-03-21
Davis, Zinna Northington (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S321000
Reexamination Certificate
active
07015238
ABSTRACT:
A novel crystalline organic acid salt of amlodipine having improved physiochemical properties, a preparation method thereof and a pharmaceutical composition comprising the same are provided.
REFERENCES:
patent: 4572909 (1986-02-01), Campbell et al.
patent: 4879303 (1989-11-01), Davison et al.
patent: 6291490 (2001-09-01), Young
patent: 1343663 (2002-04-01), None
patent: 0 089 167 (1983-09-01), None
patent: WO 99/52873 (1999-10-01), None
patent: WO 02/053542 (2002-07-01), None
Database EPODOC ′Online!; European Patent Office, The Hague, NL; XP-002265143;★abstract★& CN1 343 663 A (Fu Junchang); Apr. 10, 2002.
European Search Report; Application No. 03019777.6-2101-; Date of Completion: Dec. 16, 2003: Dated: Jan. 13, 2004.
Chae Myeong Yun
Cheon Jun Hee
Cho Seong Hwan
Jin Hae Tak
Jung Sung Hak
Cantor & Colburn LLP
CJ Corp.
Davis Zinna Northington
LandOfFree
Crystalline organic acid salt of amlodipine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline organic acid salt of amlodipine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline organic acid salt of amlodipine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3562553